Similarly, TFEB overexpression or activation by pharmacological mTOR inhibition alleviated 6-OHDA/AA toxicity and enhanced neuronal survival in both human and mouse models of PD (Zhuang et al., 2020). Here, MTOR is linked to Parkinson disease.